Could cause temporary or reversible harm; serious harm is unlikely.
Lack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling process
| Brand name | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE |
| Generic name | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE |
| Active ingredient(s) | ALBUTEROL SULFATE, IPRATROPIUM BROMIDE |
| Distributed by / for | Nephron Pharmaceuticals Corp. |
| NDC | 0487-0201-03 |
| Full product label | Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, packaged in 30x3 mL Sterile Unit-Dose Vials, a) 30 count (NDC 0487-0201-03) and b) 60 count (NDC 0487-0201-60) vials per carton, Rx only, Nephron Pharmaceutical Corporation, Orlando, FL |
| Recalling firm | Nephron Pharmaceuticals Corp. |
| Distribution | Nationwide |
| Quantity | a) 85,248 cartons and b) 35,292 cartons |
| Recall initiated | 2015-08-21 |
| Report date | 2015-10-21 |
| Recall completed | 2017-02-10 |
| Recall number | D-0010-2016 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Orlando FL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗